Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Artificial Intelligence in precision Medicine Market, by Application
1.4.2 North America Artificial Intelligence in precision Medicine Market, by Component
1.4.3 North America Artificial Intelligence in precision Medicine Market, by Technology
1.4.4 North America Artificial Intelligence in precision Medicine Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Jan – 2022, Nov) Leading Players
Chapter 4. North America Artificial Intelligence in Precision Medicine Market by Application
4.1 North America Oncology Market by Country
4.2 North America Cardiology Market by Country
4.3 North America Neurology Market by Country
4.4 North America Respiratory Market by Country
4.5 North America Others Market by Country
Chapter 5. North America Artificial Intelligence in Precision Medicine Market by Component
5.1 North America Software Market by Country
5.2 North America Hardware Market by Country
5.3 North America Service Market by Country
Chapter 6. North America Artificial Intelligence in Precision Medicine Market by Technology
6.1 North America Deep Learning Market by Country
6.2 North America Natural Language Processing Market by Country
6.3 North America Querying Method Market by Country
6.4 North America Context Aware Processing Market by Country
Chapter 7. North America Artificial Intelligence in Precision Medicine Market by Country
7.1 US Artificial Intelligence in Precision Medicine Market
7.1.1 US Artificial Intelligence in Precision Medicine Market by Application
7.1.2 US Artificial Intelligence in Precision Medicine Market by Component
7.1.3 US Artificial Intelligence in Precision Medicine Market by Technology
7.2 Canada Artificial Intelligence in Precision Medicine Market
7.2.1 Canada Artificial Intelligence in Precision Medicine Market by Application
7.2.2 Canada Artificial Intelligence in Precision Medicine Market by Component
7.2.3 Canada Artificial Intelligence in Precision Medicine Market by Technology
7.3 Mexico Artificial Intelligence in Precision Medicine Market
7.3.1 Mexico Artificial Intelligence in Precision Medicine Market by Application
7.3.2 Mexico Artificial Intelligence in Precision Medicine Market by Component
7.3.3 Mexico Artificial Intelligence in Precision Medicine Market by Technology
7.4 Rest of North America Artificial Intelligence in Precision Medicine Market
7.4.1 Rest of North America Artificial Intelligence in Precision Medicine Market by Application
7.4.2 Rest of North America Artificial Intelligence in Precision Medicine Market by Component
7.4.3 Rest of North America Artificial Intelligence in Precision Medicine Market by Technology
Chapter 8. Company Profiles
8.1 General Electric (GE) Co. (GE Healthcare)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.6 SWOT Analysis
8.2 Google LLC (Alphabet Inc.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.6 SWOT Analysis
8.3 Intel Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 SWOT Analysis
8.4 Microsoft Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 IBM Corporation
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Regional & Segmental Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 NVIDIA Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.6 SWOT Analysis
8.7 AstraZeneca PLC
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Sanofi S.A.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Tempus, Inc.
8.9.1 Company Overview
Unique Offerings 